Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-27,500
Closed -$3.69M 931
2022
Q3
$3.69M Sell
27,500
-12,500
-31% -$1.79M 0.17% 130
2022
Q2
$6.13M Sell
40,000
-14,500
-27% -$2.22M 0.25% 78
2022
Q1
$8.84M Buy
+54,500
New +$7.92M 0.32% 57
2021
Q2
Sell
-20,000
Closed -$2.16M 1060
2021
Q1
$2.16M Buy
+20,000
New +$2.14M 0.09% 214
2020
Q2
Sell
-10,000
Closed -$762K 647
2020
Q1
$762K Buy
+10,000
New +$852K 0.06% 244
2018
Q3
Sell
-26,900
Closed -$2.49M 541
2018
Q2
$2.49M Buy
+26,900
New +$2.63M 0.12% 127
2017
Q1
Sell
-17,098
Closed -$1.07M 629
2016
Q4
$1.07M Hold
17,098
0.06% 232
2016
Q3
$1.08M Hold
17,098
0.05% 246
2016
Q2
$1.06M Sell
17,098
-4,000
-19% -$244K 0.07% 227
2016
Q1
$1.21M Sell
21,098
-7,976
-27% -$445K 0.07% 209
2015
Q4
$1.72M Sell
29,074
-3,980
-12% -$229K 0.1% 172
2015
Q3
$1.8M Sell
33,054
-45,252
-58% -$2.95M 0.11% 171
2015
Q2
$5.26M Buy
+78,306
New +$5.11M 0.25% 87

Other funds holding ABBV

CSS LLC's ABBV Position: Q1 2025 in Review

CSS LLC sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 3,340 shares — an estimated $594K sold.

CSS LLC first reported a position in ABBV in Q4 2013 and held it in 30 quarters. The position peaked at $2.56M in Q2 2018. 3,826 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • CSS LLC reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • CSS LLC sold 3,340 AbbVie shares in Q1 2025, an estimated $594K.
  • CSS LLC first reported a position in AbbVie in Q4 2013 and held it in 30 quarters.
  • CSS LLC's AbbVie position peaked at $2.56M in Q2 2018.
  • 3,826 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on CSS LLC's 13F filing for Q1 2025, filed 15 May 2025.